Dapagliflozin improves insulin sensitivity and increases lipid oxidation and plasma ketone concentration in patients with type 2 diabetes, according to a study published online Aug. 25 in Diabetes Care.
Newsroom
Dapagliflozin improves insulin sensitivity and increases lipid oxidation and plasma ketone concentration in patients with type 2 diabetes, according to a study published online Aug. 25 in Diabetes Care.